A statistical genomics framework to trace bacterial genomic predictors of clinical outcomes in Staphylococcus aureus bacteremia

被引:7
作者
Giulieri, Stefano G. [1 ,2 ,3 ,4 ]
Guerillot, Romain [1 ]
Holmes, Natasha E. [3 ,4 ]
Baines, Sarah L. [1 ,5 ]
Hachani, Abderrahman [1 ]
Hayes, Ashleigh S. [1 ]
Daniel, Diane S. [1 ]
Seemann, Torsten [5 ]
Davis, Joshua S. [6 ,7 ]
Van Hal, Sebastiaan [8 ,9 ]
Tong, Steven Y. C. [2 ,3 ]
Stinear, Timothy P. [1 ]
Howden, Benjamin P. [1 ,4 ,5 ]
机构
[1] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia
[2] Royal Melbourne Hosp, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia
[3] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic 3000, Australia
[4] Austin Hlth, Dept Infect Dis, Heidelberg, Vic 3084, Australia
[5] Univ Melbourne, Ctr Pathogen Genom, Melbourne, Vic 3000, Australia
[6] John Hunter Hosp, Dept Infect Dis, New Lambton Hts, NSW 2305, Australia
[7] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT 0810, Australia
[8] Royal Prince Alfred Hosp, Dept Infect Dis & Microbiol, Camperdown, NSW 2050, Australia
[9] Univ Sydney, Cent Clin Sch, Camperdown, NSW 2050, Australia
来源
CELL REPORTS | 2023年 / 42卷 / 09期
基金
英国医学研究理事会;
关键词
REDUCED SUSCEPTIBILITY; TREATMENT FAILURE; VANCOMYCIN; RESISTANCE; MORTALITY; INFECTIONS; ASSOCIATION; DAPTOMYCIN; METABOLISM; MUTATIONS;
D O I
10.1016/j.celrep.2023.113069
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Outcomes of severe bacterial infections are determined by the interplay between host, pathogen, and treatments. While human genomics has provided insights into host factors impacting Staphylococcus aureus infections, comparatively little is known about S. aureus genotypes and disease severity. Building on the hypothesis that bacterial pathoadaptation is a key outcome driver, we developed a genome-wide association study (GWAS) framework to identify adaptive mutations associated with treatment failure and mortality in S. aureus bacteremia (1,358 episodes). Our research highlights the potential of vancomycin-selected mutations and vancomycin minimum inhibitory concentration (MIC) as key explanatory variables to predict infection severity. The contribution of bacterial variation was much lower for clinical outcomes (heritability <5%); however, GWASs allowed us to identify additional, MIC-independent candidate pathogenesis loci. Using supervised machine learning, we were able to quantify the predictive potential of these adaptive signatures. Our statistical genomics framework provides a powerful means to capture adaptive mutations impacting severe bacterial infections.
引用
收藏
页数:18
相关论文
共 50 条
[31]   Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study [J].
Mesut Yilmaz ;
Nazif Elaldi ;
İlker İnanç Balkan ;
Ferhat Arslan ;
Ayşe Alga Batırel ;
Mustafa Zahir Bakıcı ;
Mustafa Gokhan Gozel ;
Sevil Alkan ;
Aygül Doğan Çelik ;
Meltem Arzu Yetkin ;
Hürrem Bodur ;
Melda Sınırtaş ;
Halis Akalın ;
Fatma Aybala Altay ;
İrfan Şencan ;
Emel Azak ;
Sibel Gündeş ;
Bahadır Ceylan ;
Recep Öztürk ;
Hakan Leblebicioglu ;
Haluk Vahaboglu ;
Ali Mert .
Annals of Clinical Microbiology and Antimicrobials, 15
[32]   Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study [J].
Arshad, Samia ;
Huang, Vanthida ;
Hartman, Pamela ;
Perri, Mary B. ;
Moreno, Daniela ;
Zervos, Marcus J. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 57 :27-31
[33]   Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes [J].
Minejima, Emi ;
Mai, Nikki ;
Bui, Nancy ;
Mert, Melissa ;
Mack, Wendy J. ;
She, Rosemary C. ;
Nieberg, Paul ;
Spellberg, Brad ;
Wong-Beringer, Annie .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (04) :566-573
[34]   The Importance of Staphylococcus aureus Genotypes in Outcomes and Complications of Bacteremia [J].
David, Michael Z. .
CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) :1878-1880
[35]   Staphylococcus aureus Bacteremia in Hospitalized Children: Incidence and Outcomes [J].
Klieger, Sarah B. ;
Vendetti, Neika D. ;
Fisher, Brian T. ;
Gerber, Jeffrey S. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (05) :603-605
[36]   Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia [J].
Gutierrez, Johnny ;
Guimaraes, Alessander O. ;
Lewin-Koh, Nicholas ;
Berhanu, Aklile ;
Xu, Min ;
Cao, Yi ;
Kim, Janice ;
Yan, Donghong ;
Chang, Joanna K. ;
Dinoso, Jason B. ;
Koss, Catherine A. ;
Clemenzi-Allen, Angelo ;
Chambers, Henry F. ;
Peck, Melicent C. ;
Baruch, Amos ;
Rosenberger, Carrie M. .
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04)
[37]   The clinical significance of concurrent Staphylococcus aureus bacteriuria in patients with S. aureus bacteremia [J].
Choi, Seong-Ho ;
Lee, Sang-Oh ;
Choi, Jae-Phil ;
Lim, Seung Kwan ;
Chung, Jin-Won ;
Choi, Sang-Ho ;
Jeong, Jin-Yong ;
Woo, Jun Hee ;
Kim, Yang Soo .
JOURNAL OF INFECTION, 2009, 59 (01) :37-41
[38]   Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia [J].
Clemens, Evan C. ;
Chan, Jeannie D. ;
Lynch, John B. ;
Dellit, Timothy H. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (04) :408-414
[39]   Analysis of Staphylococcal Toxins and Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia [J].
Maeda, Masayuki ;
Shoji, Hisashi ;
Shirakura, Tetsuro ;
Takuma, Takahiro ;
Ugajin, Kazuhisa ;
Fukuchi, Kunihiko ;
Niki, Yoshihito ;
Ishino, Keiko .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (07) :1195-1200
[40]   Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia? [J].
Kalil, Andre C. ;
Holubar, Marisa ;
Deresinski, Stan ;
Chambers, Henry F. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)